Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 33,186 | 32,510 | 32,395 | 32,233 | N/A |
| Income taxes - deferred | -2,483 | -2,241 | -5,446 | 1,570 | 121 |
| Accounts receivable | 1,520 | 6,060 | 7,288 | -10,981 | 135 |
| Accounts payable and accrued liabilities | -70 | -2,031 | -318 | 3,051 | N/A |
| Other Working Capital | -7,665 | 1,549 | 6,455 | -8,443 | -164 |
| Other Operating Activity | -15,144 | -9,439 | -7,627 | 9,736 | -200 |
| Operating Cash Flow | $9,344 | $26,408 | $32,747 | $27,166 | $-109 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -36 | -199 | -99 | -179 | 3 |
| Net Acquisitions | N/A | N/A | -13,800 | -10,354 | N/A |
| Purchase Sale Intangibles | -44,641 | -2,360 | -682 | N/A | N/A |
| Other Investing Activity | 0 | -12,800 | 0 | 0 | 214 |
| Investing Cash Flow | $-44,677 | $-15,359 | $-14,581 | $-10,533 | $217 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,000 | 0 | 100,000 | N/A | N/A |
| Debt Repayment | -6,664 | -5,453 | -152,521 | -13,132 | N/A |
| Common Stock Issued | 0 | 37,329 | 19,470 | N/A | N/A |
| Common Stock Repurchased | N/A | 0 | -924 | N/A | -1,045 |
| Dividend Paid | -4,749 | -4,332 | -1,047 | N/A | N/A |
| Other Financing Activity | 977 | -3,597 | -7,834 | -5,078 | 0 |
| Financing Cash Flow | $9,564 | $23,947 | $-42,856 | $-18,210 | $-1,045 |
| Exchange Rate Effect | -697 | 1,152 | -599 | 33 | 0 |
| Beginning Cash Position | 47,078 | 10,930 | 36,219 | 37,763 | 26,083 |
| End Cash Position | 20,612 | 47,078 | 10,930 | 36,219 | 25,146 |
| Net Cash Flow | $-25,769 | $34,996 | $-24,690 | $-1,577 | $-937 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,344 | 26,408 | 32,747 | 27,166 | -109 |
| Capital Expenditure | -44,677 | -2,559 | -781 | -179 | N/A |
| Free Cash Flow | -35,333 | 23,849 | 31,966 | 26,987 | -109 |